- Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein

  1. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh W, Goldsmith CS, Gubler DJ, Roehrig JT, Eaton B, Gould AR, Olson J, Field H, Daniels P, Ling AE, Peters CJ, Anderson LJ, Mahy BW: Nipah virus: a recently emergent deadly paramyxovirus.

    Science 2000, 288(5470):1432-1435.

  2. Wang LF, Yu M, Hansson E, Pritchard LI, Shiell B, Michalski WP, Eaton BT: The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae.

    J Virol 2000, 74(21):9972-9979.

  3. Mayo MA: Virus taxonomy - Houston 2002.

    Arch Virol 2002, 147(5):1071-1076.

  4. Murray K, Eaton B, Hooper P, Wang L, Williamson M, Young P: Flying Foxes, Horses, and Humans: a Zoonosis Caused be a New Member of the Paramyxoviridae.In Emerging Infections. Edited by: Scheld WM, Armstrong D, Hughes JM. Washington, D.C. , ASM Press; 1998:43-58.

  5. Chua KB: Nipah virus outbreak in Malaysia.

    J Clin Virol 2003, 26(3):265-275.

  6. ICDDRB: Outbreaks of encephalitis due to Nipah/Hendra-like viruses, western Bangladesh.In Health Science Bulletin. Volume 1. ICDDR,B Centre for Health and Population Research; 2003:1-6.

  7. ICDDRB: Nipah encephalitis outbreak over wide area of western Bangladeh, 2004.

    Health Science Bulletin 2004, 2(1):7-11.

  8. ICDDRB: Person-to-person transmission of Nipah virus during outbreak in Faridpur District, 2004.

    Health Science Bulletin 2004, 2(2):5-9.

  9. Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, Niezgoda M, Rupprecht C, Bresee J, Breiman RF: Nipah virus encephalitis reemergence, Bangladesh.

    Emerg Infect Dis 2004, 10(12):2082-2087.

  10. Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, Rollin PE, Comer JA, Ksiazek TG, Hossain MJ, Gurley ES, Breiman RF, Bellini WJ, Rota PA: Genetic characterization of Nipah virus, Bangladesh, 2004.

    Emerg Infect Dis 2005, 11(10):1594-1597.

  11. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, Ksiazek TG, Mishra A: Nipah virus-associated encephalitis outbreak, Siliguri, India.

    Emerg Infect Dis 2006, 12(2):235-240.

  12. Eaton BT, Broder CC, Middleton D, Wang LF: Hendra and Nipah viruses: different and dangerous.

    Nat Rev Microbiol 2006, 4(1):23-35.

  13. Halpin K, Young PL, Field HE, Mackenzie JS: Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus.

    J Gen Virol 2000, 81(Pt 8):1927-1932.

  14. Yob JM, Field H, Rashdi AM, Morrissy C, van der Heide B, Rota P, bin Adzhar A, White J, Daniels P, Jamaluddin A, Ksiazek T: Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia.

    Emerg Infect Dis 2001, 7(3):439-441.

  15. Olson JG, Rupprecht C, Rollin PE, An US, Niezgoda M, Clemins T, Walston J, Ksiazek TG: Antibodies to Nipah-like virus in bats (Pteropus lylei), Cambodia.

    Emerg Infect Dis 2002, 8(9):987-988.

  16. Reynes JM, Counor D, Ong S, Faure C, Seng V, Molia S, Walston J, Georges-Courbot MC, Deubel V, Sarthou JL: Nipah virus in Lyle's flying foxes, Cambodia.

    Emerg Infect Dis 2005, 11(7):1042-1047.

  17. Wacharapluesadee S, Lumlertdacha B, Boongird K, Wanghongsa S, Chanhome L, Rollin P, Stockton P, Rupprecht CE, Ksiazek TG, Hemachudha T: Bat Nipah virus, Thailand.

    Emerg Infect Dis 2005, 11(12):1949-1951.

  18. Chua KB, Lek Koh C, Hooi PS, Wee KF, Khong JH, Chua BH, Chan YP, Lim ME, Lam SK: Isolation of Nipah virus from Malaysian Island flying-foxes.

    Microbes Infect 2002, 4(2):145-151.

  19. Lamb RA, Kolakofsky D: Paramyxoviridae: The viruses and their replication.In Fields Virology. 4th edition. Edited by: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE. Philadelphia, PA , Lippincott Williams & Wilkins; 2001:1305-1340.

  20. Shaw ML, Garcia-Sastre A, Palese P, Basler CF: Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively.

    J Virol 2004, 78(11):5633-5641.

  21. Park MS, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, Garcia-Sastre A, Basler CF: Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins.

    J Virol 2003, 77(2):1501-1511.

  22. Rodriguez JJ, Cruz CD, Horvath CM: Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion.

    J Virol 2004, 78(10):5358-5367.

  23. Shaw ML, Cardenas WB, Zamarin D, Palese P, Basler CF: Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways.

    J Virol 2005, 79(10):6078-6088.

  24. Bossart KN, Wang LF, Eaton BT, Broder CC: Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus.

    Virology 2001, 290(1):121-135.

  25. Bossart KN, Wang LF, Flora MN, Chua KB, Lam SK, Eaton BT, Broder CC: Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins.

    J Virol 2002, 76(22):11186-11198.

  26. Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT, Broder CC: Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.

    Proc Natl Acad Sci U S A 2005, 102(30):10652-10657.

  27. Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, Lee B: EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus.

    Nature 2005, 436(7049):401-405.

  28. Diederich S, Moll M, Klenk HD, Maisner A: The nipah virus fusion protein is cleaved within the endosomal compartment.

    J Biol Chem 2005, 280(33):29899-29903.

  29. Pager CT, Dutch RE: Cathepsin L is involved in proteolytic processing of the hendra virus fusion protein.

    J Virol 2005, 79(20):12714-12720.

  30. Pager CT, Craft WW Jr., Patch J, Dutch RE: A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L.

    Virology 2006, 346(2):251-257.

  31. Schmitt AP, Lamb RA: Escaping from the cell: assembly and budding of negative-strand RNA viruses.

    Curr Top Microbiol Immunol 2004, 283:145-196.

  32. Cathomen T, Mrkic B, Spehner D, Drillien R, Naef R, Pavlovic J, Aguzzi A, Billeter MA, Cattaneo R: A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain.

    Embo J 1998, 17(14):3899-3908.

  33. Inoue M, Tokusumi Y, Ban H, Kanaya T, Shirakura M, Tokusumi T, Hirata T, Nagai Y, Iida A, Hasegawa M: A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading.

    J Virol 2003, 77(11):6419-6429.

  34. Mebatsion T, Weiland F, Conzelmann KK: Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G.

    J Virol 1999, 73(1):242-250.

  35. Takimoto T, Murti KG, Bousse T, Scroggs RA, Portner A: Role of matrix and fusion proteins in budding of Sendai virus.

    J Virol 2001, 75(23):11384-11391.

  36. Sugahara F, Uchiyama T, Watanabe H, Shimazu Y, Kuwayama M, Fujii Y, Kiyotani K, Adachi A, Kohno N, Yoshida T, Sakaguchi T: Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein.

    Virology 2004, 325(1):1-10.

  37. Coronel EC, Murti KG, Takimoto T, Portner A: Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus- like particles containing nucleocapsid-like structures.

    J Virol 1999, 73(8):7035-7038.

  38. Pantua HD, McGinnes LW, Peeples ME, Morrison TG: Requirements for the Assembly and Release of Newcastle Disease Virus-like particles.

    J Virol 2006, 80(22):11062-11073.

  39. Justice PA, Sun W, Li Y, Ye Z, Grigera PR, Wagner RR: Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus.

    J Virol 1995, 69(5):3156-3160.

  40. Li Y, Luo L, Schubert M, Wagner RR, Kang CY: Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus.

    J Virol 1993, 67(7):4415-4420.

  41. Harty RN, Paragas J, Sudol M, Palese P: A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding.

    J Virol 1999, 73(4):2921-2929.

  42. Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP: A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

    Proc Natl Acad Sci U S A 2000, 97(25):13871-13876.

  43. Timmins J, Scianimanico S, Schoehn G, Weissenhorn W: Vesicular release of ebola virus matrix protein VP40.

    Virology 2001, 283(1):1-6.

  44. Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, Geisbert TW, Hevey M, Schmaljohn C, Schmaljohn A, Aman MJ: Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.

    J Exp Med 2002, 195(5):593-602.

  45. Noda T, Sagara H, Suzuki E, Takada A, Kida H, Kawaoka Y: Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP.

    J Virol 2002, 76(10):4855-4865.

  46. Jasenosky LD, Neumann G, Lukashevich I, Kawaoka Y: Ebola virus VP40-induced particle formation and association with the lipid bilayer.

    J Virol 2001, 75(11):5205-5214.

  47. Rolls MM, Webster P, Balba NH, Rose JK: Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA.

    Cell 1994, 79(3):497-506.

  48. Mebatsion T, Konig M, Conzelmann KK: Budding of rabies virus particles in the absence of the spike glycoprotein.

    Cell 1996, 84(6):941-951.

  49. Volchkov VE, Volchkova VA, Slenczka W, Klenk HD, Feldmann H: Release of viral glycoproteins during Ebola virus infection.

    Virology 1998, 245(1):110-119.

  50. Schmitt AP, Leser GP, Waning DL, Lamb RA: Requirements for budding of paramyxovirus simian virus 5 virus-like particles.

    J Virol 2002, 76(8):3952-3964.

  51. Conzelmann KK: Reverse genetics of mononegavirales.

    Curr Top Microbiol Immunol 2004, 283:1-41.

  52. Sutter G, Moss B: Nonreplicating vaccinia vector efficiently expresses recombinant genes.

    Proc Natl Acad Sci U S A 1992, 89(22):10847-10851.

  53. Staib C, Drexler I, Sutter G: Construction and isolation of recombinant MVA.

    Methods Mol Biol 2004, 269:77-100.

  54. Carroll MW, Moss B: E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses.

    Biotechniques 1995, 19(3):352-4, 356.

  55. Shiell BJ, Gardner DR, Crameri G, Eaton BT, Michalski WP: Sites of phosphorylation of P and V proteins from Hendra and Nipah viruses: newly emerged members of Paramyxoviridae.

    Virus Res 2003, 92(1):55-65.

  56. Wang LF, Michalski WP, Yu M, Pritchard LI, Crameri G, Shiell B, Eaton BT: A novel P/V/C gene in a new member of the Paramyxoviridae family, which causes lethal infection in humans, horses, and other animals.

    J Virol 1998, 72(2):1482-1490.

  57. Moss B: Poxviridae: The viruses and their replication.In Fields Virology. 4th edition. Edited by: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE. Philadelphia, PA , Lippincott Williams & Wilkins; 2001:2849-2883.

  58. Harcourt BH, Tamin A, Ksiazek TG, Rollin PE, Anderson LJ, Bellini WJ, Rota PA: Molecular characterization of Nipah virus, a newly emergent paramyxovirus.

    Virology 2000, 271(2):334-349.

  59. Yao Q, Hu X, Compans RW: Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces.

    J Virol 1997, 71(1):650-656.

  60. Malvoisin E, Wild TF: Measles virus glycoproteins: studies on the structure and interaction of the haemagglutinin and fusion proteins.

    J Gen Virol 1993, 74(Pt 11):2365-2372.

  61. Stone-Hulslander J, Morrison TG: Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells.

    J Virol 1997, 71(9):6287-6295.

  62. Homann HE, Hofschneider PH, Neubert WJ: Sendai virus gene expression in lytically and persistently infected cells.

    Virology 1990, 177(1):131-140.

  63. Wright PJ, Crameri G, Eaton BT: RNA synthesis during infection by Hendra virus: an examination by quantitative real-time PCR of RNA accumulation, the effect of ribavirin and the attenuation of transcription.

    Arch Virol 2005, 150(3):521-532.

  64. Goldsmith CS, Whistler T, Rollin PE, Ksiazek TG, Rota PA, Bellini WJ, Daszak P, Wong KT, Shieh WJ, Zaki SR: Elucidation of Nipah virus morphogenesis and replication using ultrastructural and molecular approaches.

    Virus Res 2003, 92(1):89-98.

  65. Hyatt AD, Zaki SR, Goldsmith CS, Wise TG, Hengstberger SG: Ultrastructure of Hendra virus and Nipah virus within cultured cells and host animals.

    Microbes Infect 2001, 3(4):297-306.

  66. Ciancanelli MJ, Basler CF: Mutation of YMYL in the Nipah virus Matrix Protein Abrogates Budding and Alters Subcellular Localization.

    J Virol 2006, 80(24):12070-12078.

  67. Coronel EC, Takimoto T, Murti KG, Varich N, Portner A: Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein.

    J Virol 2001, 75(3):1117-1123.

  68. Wang L, Harcourt BH, Yu M, Tamin A, Rota PA, Bellini WJ, Eaton BT: Molecular biology of Hendra and Nipah viruses.

    Microbes Infect 2001, 3(4):279-287.

  69. Aguilar HC, Matreyek KA, Filone CM, Hashimi ST, Levroney EL, Negrete OA, Bertolotti-Ciarlet A, Choi DY, McHardy I, Fulcher JA, Su SV, Wolf MC, Kohatsu L, Baum LG, Lee B: N-Glycans on Nipah Virus Fusion Protein Protect against Neutralization but Reduce Membrane Fusion and Viral Entry.

    J Virol 2006, 80(10):4878-4889.

  70. Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S: Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.

    Vaccine 2005, 23(23):3033-3042.

  71. Sakaguchi T, Kato A, Sugahara F, Shimazu Y, Inoue M, Kiyotani K, Nagai Y, Yoshida T: AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding.

    J Virol 2005, 79(14):8933-8941.

  72. Niwa H, Yamamura K, Miyazaki J: Efficient selection for high-expression transfectants with a novel eukaryotic vector.

    Gene 1991, 108(2):193-199.

  73. Kobasa D, Rodgers ME, Wells K, Kawaoka Y: Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks.

    J Virol 1997, 71(9):6706-6713.

  74. Mungall BA, Middleton D, Crameri G, Bingham J, Halpin K, Russell G, Green D, McEachern J, Pritchard LI, Eaton BT, Wang LF, Bossart KN, Broder CC: A feline model of acute Nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine.

    J Virol 2006, 80(24):12293-12302.

rating: 0.00 from 0 votes | updated on: 10 Oct 2007 | views: 9954 |

Rate article:

excellent! bad…